Toshihiro Yamauchi

My name is Yamauchi, and I will be serving as today's moderator. We appreciate you taking the time out of your busy schedules to attend our Investors Meeting for FY 2025 financial results, management priorities and business strategies.

Today's session will begin with a presentation by our President Mito, followed by a Q&A session, and we are scheduled to conclude at 5:45 p.m.

With that, Mr. Mito, the floor is yours.

Nobuaki Mito
President, CEO, Head of Advanced Medical Solutions Sector & Representative Director

Start the Investors Meeting for FY 2025 financial results, management priorities and business strategies. Thank you very much for attending despite your very busy schedule.

Let me start. This is my agenda for today. And here is the summary for today. First, for FY '25 results, we had very strong results. Even looking at underlying results, stripping out our games and dispositions, we had good results. And for guidance for FY 2026, underlying business performance call for solid growth in earnings power. And the driver for that is number one, Agro & Life solutions. And another is ICT and Mobility Solutions. For AGL, this time, in the U.S. Two companies were integrated to build a new company and center on that company bank rational business will be further expanded.

For ICTM, in terms of figures, it is a little slow, but